Rigshospitalet is the largest public and teaching hospital in Copenhagen and the most highly specialised hospital in Denmark. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,135 beds in Department of Infectious Diseases, Rigshospitalet.

During the past decade, Department of Infectious Diseases, Rigshospitalet conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Infectious Diseases, Rigshospitalet" #1 sponsor was "Danish HIV Research Group" with 2 trials, followed by "Susanne Dam Nielsen, MD, DMSc" with 2 trials sponsored, "Aalborg University Hospital" with 1 trials sponsored, "Scandinavian Critical Care Trials Group" with 1 trials sponsored and "Thomas Benfield" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Infectious Diseases, Rigshospitalet" #1 collaborator was "Rigshospitalet, Denmark" with 5 trials as a collaborator, "Aarhus University Hospital" with 4 trials as a collaborator, "Odense University Hospital" with 4 trials as a collaborator, "Hvidovre University Hospital" with 3 trials as a collaborator and "Aalborg University Hospital" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Department of Infectious Diseases, Rigshospitalet" are "Varicella Zoster Virus Infection" (2 trials), "Aseptic Meningitis" (1 trials), "Bacterial Meningitis" (1 trials), "Brain Abscess" (1 trials) and "Central Nervous System Infections" (1 trials). Many other conditions were trialed in "Department of Infectious Diseases, Rigshospitalet" in a lesser frequency.

Most popular intervention types in "Department of Infectious Diseases, Rigshospitalet" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3BNC117 and 10-1074" (1 trials), "Community-acquired CNS infections" (1 trials), "Different HAART regimens" (1 trials), "Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]" (1 trials) and "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Infectious Diseases, Rigshospitalet" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Department of Infectious Diseases, Rigshospitalet". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Infectious Diseases, Rigshospitalet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Infectious Diseases, Rigshospitalet, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".